Here we used deep amplicon sequencing to call low allelic fraction STAT3 somatic mutations from the CD8+ cells’ DNA in a larger set of MS cases and controls with much improved sequencing depth compared to our previous studies. This evidence concerns the gene STAT3 and myeloid sarcoma.